This contract involves the supply of the medication Burosumab as part of a treatment program for patients with X-Linked Hypophosphatemia (XLH), classified under ICD-10 code E.83.3. The contracting authority does not allow partial bids, meaning the contract cannot be divided into smaller parts. Addit
Contract awarded. Originally published 1 years ago.
No single supplier dominates the field.
In healthcare medical, INSTITUTE OF MOTHER AND CHILD has awarded 4 contracts to 4 suppliers.
Across healthcare medical, the most active winners are URTICA SP Z O O, SALUS INTERNATIONAL SP Z O O, URTICA SP Z OO — the field to beat, or your route in as a partner.
This contract involves the supply of laboratory reagents, probes, microarrays, laboratory fluids, and DNA purification and isolation kits. Suppliers can submit partial offers divided into 7 parts, and they are allowed to bid on any number of parts. Detailed descriptions and execution methods are pro
This contract involves the supply of various medical products, including medications, chemotherapy drugs, and medical devices. The buyer, the Institute of Mother and Child in Poland, is seeking suppliers who can provide these essential health products. The deadline for submitting proposals is Octobe
The contract involves the procurement of newborn screening kits for the detection of lysosomal storage diseases, specifically: Pompe disease (measuring alpha-glucosidase activity), Fabry disease (measuring alpha-galactosidase A activity), Gaucher disease (measuring glucocerebrosidase activity), and
This contract involves the supply of laboratory reagents for various genetic testing purposes, including screening for cystic fibrosis, organic acid profile analysis using GC/MS, genetic and molecular testing, QF-PCR, and NGS diagnostics. Detailed specifications and execution methods are provided in
UK Home Office seeks a global tuberculosis screening service provider to manage visa applicant testing across international locations through various delivery models.
Norfolk County Council is seeking a contractor to provide technology-enabled and virtual care services that help residents maintain independence and improve outcomes while remaining in their own homes.
Market engagement RFI for integrated criminal justice liaison, prison reentry and mental health treatment services across Lancashire and Cumbria, closing 4 September 2026.
UKHSA is seeking supplier participation in a market engagement exercise for Pralidoxime Chloride supply in 2026 through a formal Request for Information process.
